Cargando…
Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection
With the emergence of the third infectious and virulent coronavirus within the past two decades, it has become increasingly important to understand how the virus causes infection. This will inform therapeutic strategies that target vulnerabilities in the vital processes through which the virus enter...
Autores principales: | Paulsson-Habegger, Lukas, Snabaitis, Andrew K., Wren, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448535/ https://www.ncbi.nlm.nih.gov/pubmed/34543844 http://dx.doi.org/10.1016/j.bmc.2021.116389 |
Ejemplares similares
-
The role of NO in COVID-19 and potential therapeutic strategies
por: Fang, Wanyi, et al.
Publicado: (2021) -
HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
por: Ripamonti, Chiara, et al.
Publicado: (2022) -
A Review of Potential Therapeutic Strategies for COVID-19
por: Meng, Jiajia, et al.
Publicado: (2022) -
Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches
por: Gioia, Magda, et al.
Publicado: (2020) -
Regulation of cardiomyocyte DNA damage and cell death by the type 2A protein phosphatase regulatory protein alpha4
por: Cowan, Jonathan, et al.
Publicado: (2021)